Q: What are some of the biggest challenges we need to overcome to drive the adoption of clinical genomics and realize the benefits of truly personalized medicine? What promises for improved outcomes for a patient can we expect in a more technologically advanced personalized health...

Q: Severe combined immunodeficiency (SCID) is characterized by severely impaired T-cell development and is fatal without treatment. What is the current treatment of infants identified as having SCID, and what is their likely clinical outcome if treated shortly after birth? A: • Overall, with improvements in...